[Translation] A multicenter, randomized, double-blind, placebo-controlled multicenter, randomized, double-blind, placebo-controlled evaluation of the efficacy and safety of different doses of flufenidone capsules in the treatment of chronic viral hepatitis B liver fibrosis with tenofovir fumarate as basic therapy agent, parallel-controlled phase II clinical trial
主要目的:与安慰剂对照,初步评价不同剂量氟非尼酮胶囊治疗慢性乙型病毒性肝炎肝纤维化的有效性。
次要目的:初步评价不同剂量氟非尼酮胶囊治疗慢性乙型病毒性肝炎肝纤维化的安全性。
[Translation] Main objective: To preliminarily evaluate the efficacy of different doses of flufenidone capsules in the treatment of chronic hepatitis B liver fibrosis compared with placebo.
Secondary objective: To preliminarily evaluate the safety of different doses of flufenidone capsules in the treatment of chronic hepatitis B liver fibrosis.